John Gebeily
Founding Partner
Works at Kadmos Capital
Investor profile | Builders Republic
About
Founding Partner at Kadmos Capital in London, John Gebeily invests in Seed and Series A as a generalist, with a strong personal expertise in biotech, medtech, and diagnostics stemming from his operational background. He notably worked at Bristol-Myers Squibb and Serono Biotech before becoming Chief Investment Officer at Audi Capital from 2017 to 2021. He sits on the board of Plurify, Antiverse, and GlycanAge, as well as on the supervisory board of MovaLife microrobotics. He also served on the board of iFAST Diagnostics until 2024.
Profile
- Role
- Founding Partner
- Fund
- Kadmos Capital
- Nationality
- Lebanese